Icon

SAPHRIS (nda022117)- (EQ 5MG BASE,EQ 10MG BASE,EQ 2.5MG BASE)

ASENAPINE MALEATE ALLERGAN
EQ 5MG BASE,EQ 10MG BASE,EQ 2.5MG BASE
Yes No
2026-Oct-06 2014-Aug-13
None None
None No
SAPHRIS is an atypical antipsychotic indicated for: • Schizophrenia in adults • Bipolar I disorder o Acute monotherapy treatment of manic or mixed episodes, in adults and pediatric patients 10 to 17 years of age o Adjunctive treatment to lithium or valproate in adults o Maintenance monotherapy treatment in adults.
3 0 3
Total Other Developers 3
Drugs with Suitability No
EQ 5MG BASE ** ** Up - 3
EQ 10MG BASE ** ** Up - 3
EQ 2.5MG BASE ** ** - - 2
NDA Sales Available Total Generic Sales Available
Yes 3
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country
****** ************ ******* *************** ******* ******* *********** **** **. *, ************* ******* ****, *****-**, *********, ****, *********** ******, ***** (***) ***
****** ************ *** ************ ******* ******* *********** ************ ********, ****-**, ****** ***. ****& **** ** ****, ********* (*******), ********* (******), ********** ********, ********* ******, ***** (***) ***
****** ******* ******* *************** ******* *********** *********** ********, ******* *******, *.*. *******, **** *****, ****** *****,, **********, ******* ******, ***** (***) ***
****** ********** **** *** ********** ************, *** *********** **** ******** *****, ********, ************ (**) *****, ****** ****** (***) ***

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search





Expired
to
Expired
to


Please contact contact@researchdelta.com to get more details.